Business
Press Release Dec 13 2025
Biocon Limited has informed the Exchange regarding a press release dated December 13, 2025, titled "Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide".
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange regarding a press release dated December 13, 2025, titled \"Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide\". View Attachment","length":363,"tagName":"div"}]